{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:45:13Z","timestamp":1780983913832,"version":"3.54.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1097\/01.jcp.0000248620.34541.bc","type":"journal-article","created":{"date-parts":[[2007,3,19]],"date-time":"2007-03-19T07:57:26Z","timestamp":1174291046000},"page":"207-210","source":"Crossref","is-referenced-by-count":41,"title":["An Open-Label Trial of Aripiprazole Augmentation for Treatment-Resistant Generalized Anxiety Disorder"],"prefix":"10.1097","volume":"22","author":[{"given":"Matthew A.","family":"Menza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseanne D.","family":"Dobkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210128","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R2-17-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/archpsyc.1994.03950050015002","article-title":"DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.","volume":"51","author":"Wittchen","year":"1994","journal-title":"Arch Gen Psychiatry"},{"issue":"suppl 1","key":"R3-17-20210128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-3999(94)90145-7","article-title":"Cost of anxiety disorders: impact of comorbidity.","volume":"38","author":"Souetre","year":"1994","journal-title":"JPsychosom Res"},{"key":"R4-17-20210128","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1192\/bjp.168.3.308","article-title":"Phenomenology and course of generalized anxiety disorder.","volume":"168","author":"Yonkers","year":"1996","journal-title":"Br J Psychiatry"},{"issue":"suppl","key":"R5-17-20210128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0447.1998.tb05960.x","article-title":"Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS).","volume":"393","author":"Judd","year":"1998","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"R6-17-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pneurobio.2004.09.004","article-title":"Mesolimbic dopaminergic pathways in fear conditioning.","volume":"74","author":"Pezze","year":"2004","journal-title":"Prog Neurobiol"},{"issue":"8","key":"R7-17-20210128","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archpsyc.57.8.794","article-title":"A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.","volume":"57","author":"McDougle","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"R8-17-20210128","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4088\/JCP.v67n0322","article-title":"Use of atypical antipsychotics: observations from clinical practice.","volume":"67","author":"Spier","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"R9-17-20210128","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1517\/14656566.3.12.1773","article-title":"Aripiprazole: profile on efficacy and safety.","volume":"3","author":"Goodnick","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"R11-17-20210128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety status by rating.","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"R13-17-20210128","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/bmj.306.6890.1437","article-title":"Short Form 36 (SF 36) Health Survey Questionnaire; normative data for adults of working age.","volume":"306","author":"Jenkinson","year":"1993","journal-title":"BMJ"},{"key":"R15-17-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects.","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R16-17-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00004850-200501000-00002","article-title":"Aripiprazole as an augmenter of selective serotonin reuptake inhibitors in depression and anxiety disorder patients.","volume":"20","author":"Worthington","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"R17-17-20210128","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2004.11.007","article-title":"Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors.","volume":"86","author":"Adson","year":"2005","journal-title":"J Affect Dis"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.jcp.0000248620.34541.bc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:48:46Z","timestamp":1620938926000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200704000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jcp.0000248620.34541.bc","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}